ABBOTT LABORATORIES Retained Earnings 2007-2026 | ABT
Beta
What is retained earnings?
Retained earnings represent the cumulative net income that has been reinvested in the business rather than distributed as dividends to shareholders.
What is ABBOTT LABORATORIES's current retained earnings?
ABBOTT LABORATORIES (ABT) annual retained earnings for 2025 was $49.78B, a 5.33% increase from 2024. ABBOTT LABORATORIES retained earnings for the quarter ending March 31, 2026 was $49.96B.
What was ABBOTT LABORATORIES's retained earnings in 2024?
ABBOTT LABORATORIES annual retained earnings for 2024 was $47.26B, a 25.85% increase from 2023.
What was ABBOTT LABORATORIES's retained earnings in 2023?
ABBOTT LABORATORIES annual retained earnings for 2023 was $37.55B, a 6.52% increase from 2022.
What is ABBOTT LABORATORIES's 5-year retained earnings CAGR?
ABBOTT LABORATORIES retained earnings grew at a compound annual growth rate (CAGR) of 12.50% from FY2020 to FY2025, going from $27.63B to $49.78B over 5 years.
Retained Earnings History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+12.5%
FY2020
$27.63B
→
FY2025
$49.78B
07080910111213141516171819202122232425
5 years selected
Retained Earnings History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $49.78B | +5.3% | 10-K |
| FY2024 | $47.26B | +25.8% | 10-K |
| FY2023 | $37.55B | +6.5% | 10-K |
| FY2022 | $35.26B | +11.8% | 10-K |
| FY2021 | $31.53B | +14.1% | 10-K |
| FY2020 | $27.63B | +6.9% | 10-K |
| FY2019 | $25.85B | +5.2% | 10-K |
| FY2018 | $24.56B | +2.4% | 10-K |
| FY2017 | $23.98B | -6.2% | 10-K |
| FY2016 | $25.57B | -0.7% | 10-K |
| FY2015 | $25.76B | +12.6% | 10-K |
| FY2014 | $22.87B | +4.1% | 10-K |
| FY2013 | $21.98B | -9.0% | 10-K |
| FY2012 | $24.15B | +15.5% | 10-K |
| FY2011 | $20.91B | +8.8% | 10-K |
| FY2010 | $19.22B | +10.8% | 10-K |
| FY2009 | $17.34B | +25.4% | 10-K |
| FY2008 | $13.83B | +27.9% | 10-K |
| FY2007 | $10.81B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →